In US market
Dr Reddy's Laboratories has launched Paricalcitol Injection, USP, in 2 mcg, 5 mcg, 10 mcg, a therapeutic equivalent generic version of Zemplar (paricalcitol) Injection in the United States market approved by the US Food and Drug Administration.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content